34366-99-9

Upstream product

• 67-56-1 methanol 
• 122-04-3 4-nitro-benzoyl chloride 
• 136963-43-4 (4S,5R)-4,6-isopropylidenedioxy-4-p-toluenesulfonyloxyhexanal 
• 98-59-9 p-toluenesulfonyl chloride 
• 65530-31-6 (4aR,6R,8aS)-6-methoxy-2-(4-methoxyphenyl)-4,4a,6,8a-tetrahydropyrano[3,2-d][1,3]dioxine 
• 136963-32-1 methyl 2,3-dideoxy-5,6-O-isopropylidene-4-O-p-tolylsulfonyl-D-erythro-hexonate 
• 34339-61-2 methyl 2,3-dideoxy-β-D-erythro-hexopyranoside 

Relevant academic research and scientific papers

Molecular recognition XI. The synthesis of extensively deoxygenated derivatives of the H-type 2 human blood group determinant and their binding by an anti-H-type 2 monoclonal antibody and the lectin 1 of Ulex europaeus

The relative potencies of a wide variety of deoxygenated derivatives of the methyl glycoside of α-L-Fuc-(1->2)-β-D-Gal-(1->4)-β-D-GlcNAc (the H-type 2 human blood related trisaccharide) for the inhibition of the binding of an artificial H-type 2 antigen b

Synthesis of some trideoxy-D-hexoses and derivatives thereof from D-glucono-1,5-lactone

Enantiospecific syntheses of methyl 2,3,4-trideoxy-α-D- and β-D-glycero-hexopyranoside (10 and 11), methyl α-D- and β-D-amicetopyranoside (24 and 25), (2S)-1,2-hexanediol (36), (2S)-1,2,6-hexanetriol (37), and some derivatives thereof from D-glucono-1,5-lactone are described. Enantiospecific syntheses of methyl 2,3,4-trideoxy-α-D- and -β-D-glycero-hexopyranoside (10 and 11), methyl α-D- and β-D-amicetopyranoside (24 and 25), (2S)-1,2-hexanediol (36), (2S)-1,2,6-hexanetriol (37), and some derivatives thereof from D-glucono-1,5-lactone are described.